Nasal Midazolam Effects on Childhood Acute Seizures

Abstract

Sixteen children, aged from 2 months to 14 years, with a diagnosis of acute seizures and seen at Dr. Sami Ulus Child Health and Disease Center, were included in this study. Midazolam (5 mg/mL) 0.2 mg/kg was administered intranasally in 30 seconds by an injector. The heart rate, respiratory rate, blood pressure, and oxygen saturation were recorded at 0, 5, and 10 minutes after administration. The seizures of three (18.7%) patients terminated within 1 minute, of seven (43.7%) patients in 1 to 2 minutes, and of three (18.7%) patients in 2 to 5 minutes. However, three (18.7%) patients did not respond to treatment. As a result, it was concluded that intranasal midazolam administration is easy and effective. The half-life of midazolam is shorter than diazepam, and midazolam has fewer complications when compared with diazepam. It is easier to use in nasal drop and spray forms. (J Child Neurol 2000;15:833-835).

Get full access to this article

View all access options for this article.

References

Hartgraves PM , Primosch RE : An evaluation of oral and nasal midazolam for pediatric dental sedation. ASDC J Dent Child 1994;61: 175-181.

Rivera R. , Segnini M. , Baltodano A. , Perez V. : Midazolam in the treatment of status epilepticus in children. Crit Care Med 1993;21: 991-994.

Niall CT , Leigh J. , Rosen DR , Pandit UA : Preanesthetic sedation of preschool children using intranasal midazolam. Anesthesiology 1998; 69:972-975.

Jawad S. , Oxley J. , Wilson J. , et al: A pharmacodynamic evaluation of midazolam as an antiepileptic compound. J Neurol Neurosurg Psychiatry 1986 ;9:1050-1054.

Yakinci C. , Müngen B. , Şahln S. et al: Midazolam in treatment of various types of seizures in children . Brain Dev 1997;19:571-572.

Galvin GM , Jelinek GA : Midazolam: An effective agent for seizure epilepsy control. Arch Emerg Med 1987;8:169-172.

Ghilain S, Van Ruckevorsel-Harmant K, Harman J: Midazolam in the treatment of epileptic seizures. J Neurol Neurosurg Psychiatry 1988; 51:732-735.

Blumer JL : Clinical pharmacology of midazolam in infants and children. Clin Pharmacokinet 1998;35:37-47.

Lahat E. , Aladjem M. , Eshel G. , et al: Midazolam in treatment of epileptic seizures. Pediatr Neurol 1992;8:215-216.

10.

O'Regan M. , Brown JK , Clarke M. : Nasal rather than rectal benzodiazepines in the management of acute childhood seizures. Dev Med Child Neurol 1996;38:1037-1045.

11.

Lejus C. , Renaudin M. , Testa S. , et al: Midazolam for premedication in children: Nasal vs. rectal administration . Eur JAnaesthesioL 1997;14: 244-249.

12.

Remy C. , Jourdil N. , Villemain D. , et al: Intrarectal diazepam in epileptic adults. Epilepsia 1992;33:353-358.

13.

Fritz E. , Dreifuss N. , Rosman P. : A comparison of rectal diazepam gel and placebo for acute repetitive seizures . N Engl J Med 1998;25: 1869-1875.

14.

Sokic DV : Efficacy of therapy, recurrence of seizures and respiratory complications in the treatment of status epilepticus by intravenous administration of diazepam or midazolam. Srp Arh Celok Lek 1992;120: 229-232.

15.

Lugo RA , Fishbein M. , Nahata MC , Lininger B. : Complication of intranasal midazolam. Pediatrics 1993;92:638.

16.

Karl HW , Rosenberger JL , Larach MG , Ruffle JM : Transmucosal administration of midazolam for premedication of pediatric patients. Comparison of the nasal and sublingual routes. Anesthesiology 1993;78: 885-891.